AbbVie recently announced its publication in The Lancet showing that administration of Ubrelvy (ubrogepant) during the prodrome stage of a migraine can reduce the likelihood of a migraine attack developing….
Content Section:
News Posts
…60% of patients achieved a ≥50% reduction in monthly migraine days from baseline for migraine prevention, with sustained improvement in disability scores and acute medication use observed over 12 months….
Content Section:
News Posts
Via Medscape: Most patients with migraine are women. This female predominance is reflected in the clinic and in clinical trials, where ~85% are women. A pharmacologist and a neurologist from…
Content Section:
News Posts
…episodic migraine who have had prior failure on three or more migraine preventive treatments. Ajovy, from Teva Pharmaceuticals, is the first dedicated migraine preventive medication that will be available to…
Content Section:
News Posts
…specifically designed to prevent migraine. The drug should be available for patients who experience migraine on four or more days a month and who have already failed to respond to…
Content Section:
News Posts
…of migraine has been shown in many studies including Teva’s own survey of 12,545 adults with migraine – ‘Beyond Migraine’, in which 45% said migraine impacts their ability to be…
Content Section:
News Posts
…Facts and Figures https://www.migrainetrust.org/about-migraine/migraine-what-is-it/facts-figures/ (figure based on current UK adult population from the Office of National Statistics – www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/articles/overviewoftheukpopulation/february2016) [Last accessed: March 2020] Buse DC. et al. ‘Chronic Migraine Prevalence,…
Content Section:
News Posts
…a category (1.4.4) of “migraine aura-triggered seizure”, which, it is acknowledged, is “sometimes referred to as migralepsy”. This is defined as a “seizure triggered by an attack of migraine with…
Content Section:
Articles
…self-management support, and transforming outpatients. Teams in North East Essex, Salford and South West Hampshire focused on improving the management of headaches and migraine. Improved referral pathways, provision of Advice…
Content Section:
News Posts